These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10159112)

  • 21. Econometric analyses of national health expenditures: can positive economics help to answer normative questions?
    McGuire A; Parkin D; Hughes D; Gerard K
    Health Econ; 1993 Jul; 2(2):113-26. PubMed ID: 8261033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does the economics of moral hazard need to be revisited? A comment on the paper by John Nyman.
    Blomqvist A
    J Health Econ; 2001 Mar; 20(2):283-8. PubMed ID: 11252375
    [No Abstract]   [Full Text] [Related]  

  • 23. Reflections on the reflections.
    Arrow KJ
    J Health Polit Policy Law; 2001 Oct; 26(5):1197-203. PubMed ID: 11765265
    [No Abstract]   [Full Text] [Related]  

  • 24. Welfare economics and cost-utility analysis.
    Butler JR
    Dev Health Econ Public Policy; 1992; 1():143-57. PubMed ID: 10151743
    [No Abstract]   [Full Text] [Related]  

  • 25. Response to Pauly on a re-examination of the meaning and importance of supplier-induced demand.
    Labelle R; Stoddart G; Rice T
    J Health Econ; 1994 Dec; 13(4):491-4; discussion 495-6. PubMed ID: 10140535
    [No Abstract]   [Full Text] [Related]  

  • 26. Uncertainty and the welfare economics of medical care. 1963.
    Arrow KJ
    J Health Polit Policy Law; 2001 Oct; 26(5):851-83. PubMed ID: 11765268
    [No Abstract]   [Full Text] [Related]  

  • 27. Health care and economic well-being: estimating equivalence scales for public health care utilization.
    Klavus J
    Health Econ; 1999 Nov; 8(7):613-25. PubMed ID: 10544327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deadweight loss of bacterial resistance due to overtreatment.
    Elbasha EH
    Health Econ; 2003 Feb; 12(2):125-38. PubMed ID: 12563660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health insurance and market failure since Arrow.
    Glied SA
    J Health Polit Policy Law; 2001 Oct; 26(5):957-65. PubMed ID: 11765274
    [No Abstract]   [Full Text] [Related]  

  • 30. Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be?
    Birch S; Gafni A
    J Health Econ; 1992 Oct; 11(3):279-96. PubMed ID: 10122540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics.
    Bridges JF
    Appl Health Econ Health Policy; 2003; 2(4):213-24. PubMed ID: 15119540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arrow's concept of the health care consumer: a forty-year retrospective.
    Sloan FA
    J Health Polit Policy Law; 2001 Oct; 26(5):899-911. PubMed ID: 11765270
    [No Abstract]   [Full Text] [Related]  

  • 33. General equilibrium and marketability in the health care industry.
    Chernew M
    J Health Polit Policy Law; 2001 Oct; 26(5):885-97. PubMed ID: 11765269
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of the capital markets in restructuring health care.
    Silvers JB
    J Health Polit Policy Law; 2001 Oct; 26(5):1019-30. PubMed ID: 11765253
    [No Abstract]   [Full Text] [Related]  

  • 35. The market for medical ethics.
    Bloche MG
    J Health Polit Policy Law; 2001 Oct; 26(5):1099-112. PubMed ID: 11765259
    [No Abstract]   [Full Text] [Related]  

  • 36. Consolidations and closures: an empirical analysis of exits from the hospital industry.
    Harrison TD
    Health Econ; 2007 May; 16(5):457-74. PubMed ID: 17031782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical service risk and the evolution of provider compensation arrangements.
    Bazzoli GJ
    J Health Polit Policy Law; 2001 Oct; 26(5):1003-18. PubMed ID: 11765252
    [No Abstract]   [Full Text] [Related]  

  • 38. The demand for physician services. Evidence from a natural experiment.
    Cockx B; Brasseur C
    J Health Econ; 2003 Nov; 22(6):881-913. PubMed ID: 14604552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health insurance: the tradeoff between risk pooling and moral hazard.
    Manning WG; Marquis MS
    J Health Econ; 1996 Oct; 15(5):609-39. PubMed ID: 10164045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Managing uncertainty: intermediate organizations as triple agents.
    Casalino L
    J Health Polit Policy Law; 2001 Oct; 26(5):1055-68. PubMed ID: 11765256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.